“Zanidatamab in HER2-Positive Biliary Tract Cancer: A First Narrative Literature Review” (2025) Journal of Medical Health Research and Psychiatry, 2(2), pp. 1–4. doi:10.70844/jmhrp.2025.2.2.44.